PTK2 and hepatocellular carcinoma: Therefore, targeting FAK represents a promising strategy to enhance immunotherapy outcomes in HCC.<h4>Methods</h4>We analyzed RNA-sequencing data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) to compare <i>PTK2</i> (encoding FAK) expression between HCC tumors and adjacent normal tissues.